OTC Switch Offers Firms Opportunities To Diversify Earnings – Morgan Stanley
This article was originally published in The Tan Sheet
Executive Summary
Rx-to-OTC switches offer drug firms a "meaningful opportunity" to diversify their earnings, which is gaining importance in an "increasingly challenging pharmaceutical landscape" Morgan Stanley market analysts say